Education
About Us
Working with TipRanks
Follow Us
Opus Genetics (IRD)
NASDAQ:IRD
Total Valuation
Opus Genetics has a market cap or net worth of $66.22M. The enterprise value is $28.28M.
Market Cap$66.22M
Enterprise Value$28.28M
Share Statistics
Opus Genetics has 59,661,198 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding59,661,198
Owned by Insiders23.52%
Owned by Institutions20.73%
Financial Efficiency
Opus Genetics’s return on equity (ROE) is -8.56 and return on invested capital (ROIC) is -242.79%.
Return on Equity (ROE)-8.56
Return on Assets (ROA)-1.56
Return on Invested Capital (ROIC)-242.79%
Return on Capital Employed (ROCE)-2.43
Revenue Per Employee610.67K
Profits Per Employee-3.20M
Employee Count18
Asset Turnover0.30
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Opus Genetics is ―. Opus Genetics’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value4.73
Price to FCF―
Price to Operating Cash Flow-2.31
PEG Ratio―
Income Statement
In the last 12 months, Opus Genetics had revenue of 10.99M and earned -57.53M in profits. Earnings per share was -2.15.
Revenue10.99M
Gross Profit10.98M
Operating Income-62.07M
Pretax Income-57.53M
Net Income-57.53M
EBITDA-57.52M
Earnings Per Share (EPS)-2.15
Cash Flow
In the last 12 months, operating cash flow was -31.83M and capital expenditures 0.00, giving a free cash flow of -31.83M billion.
Operating Cash Flow-31.83M
Free Cash Flow-31.83M
Free Cash Flow per Share-0.53
Dividends & Yields
Opus Genetics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change-4.84%
50-Day Moving Average1.06
200-Day Moving Average1.05
Relative Strength Index (RSI)60.22
Average Volume (3m)192.59K
Important Dates
Opus Genetics upcoming earnings date is Nov 18, 2025, After Close (Confirmed).
Last Earnings DateAug 13, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date―
Financial Position
Opus Genetics as a current ratio of 3.24, with Debt / Equity ratio of 0.00%
Current Ratio3.24
Quick Ratio3.24
Debt to Market Cap0.00
Net Debt to EBITDA0.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Opus Genetics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Opus Genetics EV to EBITDA ratio is -0.35, with an EV/FCF ratio of -0.79.
EV to Sales1.85
EV to EBITDA-0.35
EV to Free Cash Flow-0.79
EV to Operating Cash Flow-0.79
Balance Sheet
Opus Genetics has $32.43M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$32.43M billion.
Cash & Marketable Securities$32.43M
Total Debt$0.00
Net Cash-$32.43M
Net Cash Per Share-$0.54
Tangible Book Value Per Share$0.25
Margins
Gross margin is 81.25%, with operating margin of -564.72%, and net profit margin of -523.40%.
Gross Margin81.25%
Operating Margin-564.72%
Pretax Margin-523.40%
Net Profit Margin-523.40%
EBITDA Margin-523.31%
EBIT Margin-523.40%
Analyst Forecast
The average price target for Opus Genetics is $6.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.00
Price Target Upside408.47% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast-6.25%
EPS Growth Forecast-226.01%